JP2010512779A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512779A5 JP2010512779A5 JP2009542273A JP2009542273A JP2010512779A5 JP 2010512779 A5 JP2010512779 A5 JP 2010512779A5 JP 2009542273 A JP2009542273 A JP 2009542273A JP 2009542273 A JP2009542273 A JP 2009542273A JP 2010512779 A5 JP2010512779 A5 JP 2010512779A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant
- strand rna
- segmented
- rna virus
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001493065 dsRNA viruses Species 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 108091005981 phosphorylated proteins Proteins 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06292025.1 | 2006-12-22 | ||
| EP06292025.1A EP1939214B1 (en) | 2006-12-22 | 2006-12-22 | Cells and methodology to generate non-segmented negative-strand RNA viruses |
| PCT/IB2007/004444 WO2008078198A2 (en) | 2006-12-22 | 2007-12-21 | Cells and methodology to generate non-segmented negative-strand rna viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014169418A Division JP2015015955A (ja) | 2006-12-22 | 2014-08-22 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512779A JP2010512779A (ja) | 2010-04-30 |
| JP2010512779A5 true JP2010512779A5 (https=) | 2014-10-16 |
| JP5902371B2 JP5902371B2 (ja) | 2016-04-13 |
Family
ID=37831098
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542273A Active JP5902371B2 (ja) | 2006-12-22 | 2007-12-21 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
| JP2014169418A Pending JP2015015955A (ja) | 2006-12-22 | 2014-08-22 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014169418A Pending JP2015015955A (ja) | 2006-12-22 | 2014-08-22 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8586364B2 (https=) |
| EP (2) | EP1939214B1 (https=) |
| JP (2) | JP5902371B2 (https=) |
| KR (1) | KR101469007B1 (https=) |
| CN (2) | CN104745533A (https=) |
| BR (1) | BRPI0719469C1 (https=) |
| CA (1) | CA2673262C (https=) |
| DK (2) | DK1939214T3 (https=) |
| ES (2) | ES2423518T3 (https=) |
| MX (1) | MX2009006755A (https=) |
| WO (1) | WO2008078198A2 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1375670B1 (en) | 2002-06-20 | 2013-06-12 | Institut Pasteur | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| EP1375512B1 (en) | 2002-06-20 | 2009-07-22 | Institut Pasteur | Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| CA2432738A1 (en) | 2003-02-26 | 2004-08-26 | Philippe Despres | New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| WO2012038832A2 (en) * | 2010-09-24 | 2012-03-29 | Institut Pasteur | Generation of replicating chimeric measles virus - retrovirus particles |
| CN103906843B (zh) * | 2011-06-08 | 2016-12-07 | 维什瓦斯·乔希 | 双质粒哺乳动物表达系统 |
| FR2994697B1 (fr) * | 2012-08-24 | 2016-05-13 | Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) | Souche vaccinale marquee du virus de la peste des petits ruminants, et son procede d'obtention |
| EP2712871A1 (en) | 2012-09-27 | 2014-04-02 | Institut Pasteur | Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications |
| EP2759301A1 (en) | 2013-01-24 | 2014-07-30 | Institut Pasteur | Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-DeltaC virus) |
| US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
| WO2015092710A1 (en) | 2013-12-19 | 2015-06-25 | Glaxosmithkline Biologicals, S.A. | Contralateral co-administration of vaccines |
| US11535864B2 (en) | 2015-01-05 | 2022-12-27 | Vishwas Dattatraya JOSHI | DNA molecules producing custom designed replicating and non-replicating negative stranded RNA viruses and uses there of |
| EP3184119A1 (en) | 2015-12-23 | 2017-06-28 | Themis Bioscience GmbH | Chromatography based purification strategies for measles scaffold based viruses |
| EP3255056A1 (en) * | 2016-06-06 | 2017-12-13 | Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives | Method for producing self-assemblying paramyxoviral nucleocapsid-like particles and their uses |
| US11351246B2 (en) | 2017-05-09 | 2022-06-07 | Invectys SAS | Recombinant measles vaccine expressing hTERT |
| EP3412307A1 (en) | 2017-06-07 | 2018-12-12 | Institut Pasteur | Recombinant measles virus expressing zika virus proteins and their applications |
| CN107557340A (zh) * | 2017-09-26 | 2018-01-09 | 南京普菲科医药科技有限公司 | 一种可诱导性拯救弹状病毒的细胞系及其构建方法与应用 |
| CN111683959A (zh) | 2017-11-09 | 2020-09-18 | 巴斯德研究院 | 包含非结构蛋白的寨卡病毒嵌合多表位及其在免疫原性组合物中的用途 |
| EP3727411A2 (en) | 2017-12-21 | 2020-10-28 | Institut Pasteur | Lassa vaccine |
| WO2020012037A1 (en) * | 2018-07-13 | 2020-01-16 | Valneva Se | Method for rescuing and producing a virus in avian cells |
| CN109355301A (zh) * | 2018-08-22 | 2019-02-19 | 深圳大学 | 一种石斑鱼重组NNVcp的密码子优化的核酸序列、融合表达载体、制备方法及其本身 |
| CN111218474A (zh) * | 2018-11-23 | 2020-06-02 | 成都生物制品研究所有限责任公司 | 一种副粘病毒的拯救系统和副粘病毒拯救方法 |
| EP3673917A1 (en) | 2018-12-28 | 2020-07-01 | Themis Bioscience GmbH | Norovirus vaccines |
| CN109913423A (zh) * | 2019-03-27 | 2019-06-21 | 扬州大学 | 一种稳定表达猪德尔塔冠状病毒N蛋白的重组Vero细胞系及应用 |
| EP3865180A1 (en) | 2020-02-13 | 2021-08-18 | Institut Pasteur | Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses |
| CA3166811A1 (en) | 2020-02-13 | 2021-08-19 | Nicolas Robert Xavier Escriou | Measles-vectored covid-19 immunogenic compositions and vaccines |
| WO2021222228A1 (en) * | 2020-04-27 | 2021-11-04 | Ohio State Innovation Foundation | A live attenuated measles virus vectored vaccine for sars-cov-2 |
| EP3936517A1 (en) * | 2020-07-08 | 2022-01-12 | Institut Pasteur | An improved measles virus vaccine vector based on multiple tandem additional transcription units |
| WO2022152818A1 (en) | 2021-01-13 | 2022-07-21 | Viroxis | Measles-hiv or measles-htlv vaccine |
| WO2023230598A2 (en) * | 2022-05-27 | 2023-11-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Reverse genetics system for feline morbillivirus |
| EP4501946A1 (en) | 2023-07-31 | 2025-02-05 | LoopLab Bio GmbH | Self-amplifying biologics for targeted therapy |
| WO2026013289A1 (en) | 2024-07-12 | 2026-01-15 | Institut Pasteur | Measles-mumps-rubella (mmr) vaccines |
| CN120648655B (zh) * | 2025-08-21 | 2026-02-13 | 内蒙古自治区农牧业科学院 | 一株t7-293t细胞及其在牛副流感病毒3型感染性克隆拯救病毒中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE181112T1 (de) * | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| ATE351916T1 (de) | 1999-10-12 | 2007-02-15 | Pasteur Institut | Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten |
| EP1311539A2 (en) | 2000-06-16 | 2003-05-21 | Institut Pasteur | Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| EP1375670B1 (en) | 2002-06-20 | 2013-06-12 | Institut Pasteur | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| DE10234579A1 (de) * | 2002-07-30 | 2004-02-12 | Zf Friedrichshafen Ag | Getriebe |
| CN1871355B (zh) * | 2003-06-09 | 2011-12-14 | 惠氏 | 从cDNA中回收非节段性负链RNA病毒的改进方法 |
| EP2361974A1 (fr) | 2003-12-02 | 2011-08-31 | Institut Pasteur | Utilisation des proteines et des peptides codés par le genome d'une nouvelle souche de coronavirus associé au SRAS |
| FR2870126B1 (fr) | 2004-05-17 | 2009-07-17 | Pasteur Institut | Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin |
| WO2006108241A1 (en) * | 2005-04-14 | 2006-10-19 | The University Of Queensland | Immunomodulating compositions and uses therefor |
-
2006
- 2006-12-22 ES ES06292025T patent/ES2423518T3/es active Active
- 2006-12-22 EP EP06292025.1A patent/EP1939214B1/en active Active
- 2006-12-22 DK DK06292025.1T patent/DK1939214T3/da active
-
2007
- 2007-12-21 CA CA2673262A patent/CA2673262C/en active Active
- 2007-12-21 WO PCT/IB2007/004444 patent/WO2008078198A2/en not_active Ceased
- 2007-12-21 CN CN201510019183.6A patent/CN104745533A/zh active Pending
- 2007-12-21 EP EP07870468.1A patent/EP2091962B1/en active Active
- 2007-12-21 ES ES07870468.1T patent/ES2686168T3/es active Active
- 2007-12-21 BR BRPI0719469A patent/BRPI0719469C1/pt active IP Right Grant
- 2007-12-21 US US12/448,468 patent/US8586364B2/en active Active
- 2007-12-21 DK DK07870468.1T patent/DK2091962T3/en active
- 2007-12-21 CN CN200780047473A patent/CN101631798A/zh active Pending
- 2007-12-21 KR KR1020097015426A patent/KR101469007B1/ko active Active
- 2007-12-21 JP JP2009542273A patent/JP5902371B2/ja active Active
- 2007-12-21 MX MX2009006755A patent/MX2009006755A/es active IP Right Grant
-
2013
- 2013-10-15 US US14/054,748 patent/US9499799B2/en active Active
-
2014
- 2014-08-22 JP JP2014169418A patent/JP2015015955A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512779A5 (https=) | ||
| Cowan et al. | Enhancing the functional properties of thermophilic enzymes by chemical modification and immobilization | |
| JP2011062217A5 (https=) | ||
| JP2015119730A5 (https=) | ||
| NZ590144A (en) | Influenza virus-like particles (vlps) comprising hemagglutinin | |
| WO2007002008A3 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells | |
| JP2010227108A5 (https=) | ||
| WO2007124327A3 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells | |
| JP2007175057A5 (https=) | ||
| JP2012503478A5 (https=) | ||
| JP2012095652A5 (https=) | ||
| JP2010279377A5 (https=) | ||
| JP2011525793A5 (https=) | ||
| WO2008099189A3 (en) | Herpes simplex viruses and methods of viral replication | |
| WO2007048089A3 (en) | Multi-plasmid system for the production of influenza virus | |
| PH12013502600A1 (en) | Rabies virus like particle production in plants | |
| WO2011106368A3 (en) | Amplification methods to minimise sequence specific bias | |
| WO2008129971A1 (ja) | 改良された持続感染型センダイウイルスベクター | |
| WO2013049121A3 (en) | Recombinant phage and methods | |
| Pejman et al. | Gradient-based hybrid topology/shape optimization of bioinspired microvascular composites | |
| MX2018006627A (es) | Aumentar el rendimiento de particulas similares a virus en plantas. | |
| CN102858375A (zh) | 载有干扰核糖核酸的细胞微粒子、其制备方法及其应用 | |
| WO2009099877A3 (en) | Closterovirus vectors and methods | |
| JP2021520815A5 (https=) | ||
| EA201400192A1 (ru) | Клетка, ферментирующая пентозы |